(Date:10/10/2008)...uring the 1950s, Austrian and Swiss scientists con...Nepal taking photographs of the glaciers, mountain...ciologist Fritz Mller spent eight months in the re...photographing the Himalayan glaciers. , Now, fif...ken by these scientists are of immense value in tr...
(Date:10/9/2008)...egistration to the IOF World Congress on Osteoporo...e only until October 31, 2008. , To benefit fro... http://www.iofbonehealth.org/wco/2008/homepage.ht...participants from non-OECD countries and for IOF m...ration, at higher rates, will be possible. , Yo...
(Date:10/9/2008)...t the European Molecular Biology Laboratory (EMBL)...irst complete developmental blueprint of a vertebr...could for the first time track all cells for the f... was reconstructed into a three-dimensional, digit...hed in the current online issue of Science , gran...
(Date:10/9/2008)...lif. Essential for life in higher animals, vitami...kets and osteoporosis, is now recognized as a majo...emphasizes UC Riverside,s Anthony Norman , an int...lished in the August issue of the American Journ...min D,s potential for contributions to good health...
Breaking Biology News(10 mins):'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 2'Himalaya -- Changing Landscapes' photo exhibition draws attention to the impacts of climate change 3Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 2Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist 3Air Methods Provides 1st Quarter Update 17399 1Air Methods Provides 1st Quarter Update 17399 2Air Methods Provides 1st Quarter Update 17399 3Damian DellAnno Joins Formation Capital as Chief Operating Officer 17394 1Damian DellAnno Joins Formation Capital as Chief Operating Officer 17394 2Lorus initiates development program exploring novel route of administration for LOR 2040 4756 1Lorus initiates development program exploring novel route of administration for LOR 2040 4756 2Lorus initiates development program exploring novel route of administration for LOR 2040 4756 3Lorus initiates development program exploring novel route of administration for LOR 2040 4756 4Pharsight Announces Fiscal Fourth Quarter 2008 and Year End Earnings Release Date and Conference Call 17392 1Pharsight Announces Fiscal Fourth Quarter 2008 and Year End Earnings Release Date and Conference Call 17392 2(Date:10/9/2008)...tCall/ - Dr. Brad Thompson, President,and CEO of O...ill present a,corporate overview of the Company at...n London, U.K. on Monday, October 13 at 2 p.m. The... II Conference Centre from October,12-14, 2008., ...lgary-based biotechnology company focused on the,d...
(Date:10/9/2008)...-FirstCall/ -- eResearchTechnology,Inc. (eRT), (N...ECG and,eClinical technology, ePRO and other servi...device, and related industries, announced today th...for the period ended,September 30, 2008 on Thursda... the release, the Company will host a conference c...
(Date:10/9/2008)...he achievement of several,value-creating, develop... LAVAL, QC, Oct. 9 / The Bo...ources Inc. ("Neptune") (NASDAQ.NEPT -,TSX.V.NTB) ...leted as of,October 8, 2008, the private placement...eeds of $2,750,000., The convertible debentures b...
(Date:10/9/2008).../ -- Horizon Therapeutics, Inc., a,privately held ...bert J. De,Vaere has joined the Company as executi...Bob is an experienced executive who brings more th...Horizon, including the last decade in,healthcare w...hy P.,Walbert, president and chief executive offic...
Breaking Biology Technology:Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2eResearchTechnology, Inc. to Announce 2008 Third Quarter Results on October 30, 2008 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 2Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 3Neptune Technologies successfully completes $2.75 million private placement with 10% management participation 4Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer 2...igley, Tosoh Bioscience LLC and Richard Cornell, W..., During a recent method optimization and i...eatment with bovine serum albumin improved reprodu...ical SEC analysis of fractions pulled from a multi...kDa apparent molecular weight protein , f...
... Introduction , While full coverag...of , HPLC as a reliable high efficiency t...ent years that such column types are not suited fo...pounds under low organic or aqueous mobile phase c...rating a polar group in the alkyl bonded phase ,...
... Karl-Heinz Esser, multiBIND biotec GmbH, ..., , Prof. Dr. Thomas Lisowsky, multi..., Advanced experiments in gene technolog...A molecules,are sufficient to cause infections, ...2]. Additionally, the,complete decontamination o...
, , Minimum Analytical Instrument Requirement: , Adept HPLC System 1, isocratic , UV/Visible HPLC detector, , Typical Method: , Column: Nucleosil
Other Biology Technology:Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns 2Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns 3Improve Recovery and Reproducibility with Pre-Treatment of Analytical TSK-GEL G3000SWXL Size Exclusion Columns 4Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns 2New Insights Into DNA Decontamination 2New Insights Into DNA Decontamination 3New Insights Into DNA Decontamination 4New Insights Into DNA Decontamination 5The Lambda Control Kit contains lambda DNA and two 25mer primers, which can be used to amplify a 500bp fragment. The lambda DNA is purified by CsCl gradient centrifugation and organic extraction foll
...lymerase. It is a 5'-exo-minus N-terminally trunca...om a gene construct in E. coli, translation initia...ain of the DNA polymerase-encoding gene. The enzym...e DNA polymerase activity in comparison with Taq D...
Homo sapiens similar to Cytosolic acyl coenzyme A thioester hydrolase Antigen: Peptide
96 Well Base Plate
Biology Products: